Fair Value Measures and Disclosures Liabilities Recurring Basis Unobservable Input Reconciliation Hospira (Details) - USD ($) $ in Thousands |
3 Months Ended | ||||
---|---|---|---|---|---|
Sep. 30, 2020 |
Mar. 31, 2022 |
Dec. 31, 2021 |
Sep. 30, 2021 |
Dec. 31, 2020 |
|
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |||||
CONTINGENT EARN-OUT LIABILITY | $ 2,589 | $ 57,701 | |||
Pursuit Vascular, Inc. [Member] | |||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | |||||
CONTINGENT EARN-OUT LIABILITY | $ 26,300 | $ 26,300 | $ 26,300 | ||
Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) | $ 0 |